Familial Predisposition and Genetic Risk Factors Associated with Pancreatic Cancer

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      PDF Download and 24 Hours Online Access
      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Gastrointestinal Endoscopy Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rahib L.
        • Smith B.D.
        • Aizenberg R.
        • et al.
        Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
        Cancer Res. 2014; 74: 2913-2921
        • Tempero M.A.
        • Malafa M.P.
        • Chiorean E.G.
        • et al.
        Pancreatic adenocarcinoma, version 1.2019.
        J Natl Compr Canc Netw. 2019; 17: 202-210
        • Klein A.P.
        • Brune K.A.
        • Petersen G.M.
        • et al.
        Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.
        Cancer Res. 2004; 64: 2634-2638
        • Brune K.A.
        • Lau B.
        • Palmisano E.
        • et al.
        Importance of age of onset in pancreatic cancer kindreds.
        J Natl Cancer Inst. 2010; 102: 119-126
        • Canto M.I.
        • Almario J.A.
        • Schulick R.D.
        • et al.
        Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance.
        Gastroenterology. 2018; 155: 740-751 e2
        • Hruban R.H.
        • Canto M.I.
        • Goggins M.
        • et al.
        Update on familial pancreatic cancer.
        Adv Surg. 2010; 44: 293-311
        • Chaffee K.G.
        • Oberg A.L.
        • McWilliams R.R.
        • et al.
        Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
        Genet Med. 2018; 20: 119-127
        • Brand R.E.
        • Lerch M.M.
        • Rubinstein W.S.
        • et al.
        Advances in counselling and surveillance of patients at risk for pancreatic cancer.
        Gut. 2007; 56: 1460-1469
        • Chen F.
        • Childs E.J.
        • Mocci E.
        • et al.
        Analysis of heritability and genetic architecture of pancreatic cancer: a PanC4 study.
        Cancer Epidemiol Biomarkers Prev. 2019; 28: 1238-1245
        • Zhen D.B.
        • Rabe K.G.
        • Gallinger S.
        • et al.
        BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
        Genet Med. 2015; 17: 569-577
        • Hu C.
        • Hart S.N.
        • Bamlet W.R.
        • et al.
        Prevalence of pathogenic mutations in cancer predisposition genes among pancreatic cancer patients.
        Cancer Epidemiol Biomarkers Prev. 2016; 25: 207-211
        • Shindo K.
        • Yu J.
        • Suenaga M.
        • et al.
        Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma.
        J Clin Oncol. 2017; 35: 3382-3390
        • Hu C.
        • Hart S.N.
        • Polley E.C.
        • et al.
        Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
        JAMA. 2018; 319: 2401-2409
      1. Daly M, Pal T, Berry M, et al. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2021;19(1):77-102.

        • Ibrahim I.S.
        • Wasser M.N.
        • Wu Y.
        • et al.
        High growth rate of pancreatic ductal adenocarcinoma in CDKN2A-p16-Leiden mutation carriers.
        Cancer Prev Res (Phila). 2018; 11: 551-556
        • Vasen H.F.
        • Gruis N.A.
        • Frants R.R.
        • et al.
        Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
        Int J Cancer. 2000; 87: 809-811
        • McWilliams R.R.
        • Wieben E.D.
        • Chaffee K.G.
        • et al.
        CDKN2A germline rare coding variants and risk of pancreatic cancer in minority populations.
        Cancer Epidemiol Biomarkers Prev. 2018; 27: 1364-1370
        • Hofstatter E.W.
        • Domchek S.M.
        • Miron A.
        • et al.
        PALB2 mutations in familial breast and pancreatic cancer.
        Fam Cancer. 2011; 10: 225-231
        • Aslanian H.R.
        • Lee J.H.
        • Canto M.I.
        AGA clinical practice update on pancreas cancer screening in high-risk individuals: expert review.
        Gastroenterology. 2020; 159: 358-362
        • Roberts N.J.
        • Jiao Y.
        • Yu J.
        • et al.
        ATM mutations in patients with hereditary pancreatic cancer.
        Cancer Discov. 2012; 2: 41-46
        • Provenzale D.
        • Gupta S.
        • Ahnen D.J.
        • et al.
        Genetic/familial high-risk assessment: colorectal version 1.2016, NCCN clinical practice guidelines in oncology.
        J Natl Compr Canc Netw. 2016; 14: 1010-1030
      2. Gupta S, Weiss J, Axell L, et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019. J Natl Compr Canc Netw, 2019;17(9):1032-41.

        • Korsse S.E.
        • Harinck F.
        • van Lier M.G.
        • et al.
        Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillance.
        J Med Genet. 2013; 50: 59-64
        • Resta N.
        • Pierannunzio D.
        • Lenato G.M.
        • et al.
        Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study.
        Dig Liver Dis. 2013; 45: 606-611
        • Ruijs M.W.G.
        • Verhoef S.
        • Rookus M.A.
        • et al.
        <em>TP53</em> germline mutation testing in 180 families suspected of Li–Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
        J Med Genet. 2010; 47: 421
        • Lowenfels A.B.
        • Maisonneuve P.
        • DiMagno E.P.
        • et al.
        Hereditary pancreatitis and the risk of pancreatic cancer.
        J Natl Cancer Inst. 1997; 89: 442-446
        • Hasan A.
        • Moscoso D.I.
        • Kastrinos F.
        The role of genetics in pancreatitis.
        Gastrointest Endosc Clin N Am. 2018; 28: 587-603
        • Comfort M.W.
        • Steinberg A.G.
        Pedigree of a family with hereditary chronic relapsing pancreatitis.
        Gastroenterology. 1952; 21: 54-63
        • Whitcomb D.C.
        • Gorry M.C.
        • Preston R.A.
        • et al.
        Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene.
        Nat Genet. 1996; 14: 141-145
        • Witt H.
        • Luck W.
        • Hennies H.C.
        • et al.
        Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis.
        Nat Genet. 2000; 25: 213-216
        • Zielenski J.
        Genotype and phenotype in cystic fibrosis.
        Respiration. 2000; 67: 117-133
        • Nissim S.
        • Leshchiner I.
        • Mancias J.D.
        • et al.
        Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer.
        Nat Genet. 2019; 51: 1308-1314
        • Lowery M.A.
        • Wong W.
        • Jordan E.J.
        • et al.
        Prospective evaluation of germline alterations in patients with exocrine pancreatic neoplasms.
        J Natl Cancer Inst. 2018; 110: 1067-1074
        • Golan T.
        • Hammel P.
        • Reni M.
        • et al.
        Maintenance Olaparib for Germline BRCA-mutated metastatic pancreatic cancer.
        N Engl J Med. 2019; 381: 317-327
        • Young E.L.
        • Thompson B.A.
        • Neklason D.W.
        • et al.
        Pancreatic cancer as a sentinel for hereditary cancer predisposition.
        BMC Cancer. 2018; 18: 697
        • Galeotti A.A.
        • Gentiluomo M.
        • Rizzato C.
        • et al.
        Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction.
        J Med Genet. 2021; 58: 369-377
        • Force UPST
        Screening for Pancreatic cancer: US preventive services task force reaffirmation recommendation statement.
        JAMA. 2019; 322: 438-444
        • Lucas A.L.
        • Kastrinos F.
        Screening for pancreatic cancer.
        JAMA. 2019; 322: 407-408
        • Canto M.I.
        • Harinck F.
        • Hruban R.H.
        • et al.
        International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
        Gut. 2013; 62: 339-347
        • Syngal S.
        • Brand R.E.
        • Church J.M.
        • et al.
        ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
        Am J Gastroenterol. 2015; 110 ([quiz 263]): 223-262
        • Goggins M.
        • Overbeek K.A.
        • Brand R.
        • et al.
        Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
        Gut. 2020; 69: 7-17
        • Overbeek K.A.
        • Cahen D.L.
        • Canto M.I.
        • et al.
        Surveillance for neoplasia in the pancreas.
        Best Pract Res Clin Gastroenterol. 2016; 30: 971-986
      3. Lorenzo D, Rebours V, Maire F, et al. Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer. World J Gastroenterol 2019;25(34):5082-96.

        • Stoffel E.M.
        • McKernin S.E.
        • Brand R.
        • et al.
        Evaluating susceptibility to pancreatic cancer: ASCO provisional clinical opinion.
        J Clin Oncol. 2019; 37: 153-164
        • Llach J.
        • Carballal S.
        • Moreira L.
        Familial pancreatic cancer: current perspectives.
        Cancer Manag Res. 2020; 12: 743-758